BioSpace News Archive

Efficient versatile ready-for-rapid building system of negative pressure room MCM will serve as both a triage unit and bridge center in emergency medical situations

The size of the notes offering was increased from the previously announced amount. The offerings of the shares and the notes are expected to close on or about January 11, 2021, subject to the satisfaction of customary closing conditions.

Molecular-based Disease Screening shall find widespread application of blood transfusion diagnostics, capturing over 70% of the market.

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that it will participate in two upcoming investor conferences.

OpSens Inc. (“OpSens” or the “Company”) (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, will report financial results for its first quarter of fis

Leading academic health center aims to improve the care experience and reduce physician burnout after a successful pilot found Nuance DAX cuts time spent on clinical documentation by more than half

Theralink Technologies (OTC: OBMP) (“Theralink” or the “Company”) , a molecular profiling company specializing in patented, biomarker assay services that target multiple areas of oncology, today issued a letter to shareholders from it

TwinStrand Biosciences, Inc., a next-generation DNA sequencing technology company, announced today that Gary Gilliland , M.D., Ph.D., has been appointed to its Board of Directors as the company’s fifth board member. Dr. Gillilan

Sana Biotechnology, Inc. (Sana), focused on creating and delivering engineered cells as medicines, announced today that Ke Liu , M.D., Ph.D., has joined the senior leadership team as Sana’s Head of Regulatory Affairs & Strategy.

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a specialty pharmaceutical company developing and commercializing critical care drug products, today announced that it will be presenting at two virtual investor conferences during the month of January 2021 . H.C. Wainwright BioConnect 2021 Virtual Confere